Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
11%
Acinetobacter Baumannii
27%
Acute Pyelonephritis
26%
Adverse Event
28%
Antibiotic Resistance
12%
Antibiotic Therapy
23%
Antibiotics
27%
Antiinfective Agent
19%
Antimicrobial Agent
24%
Antimicrobial Therapy
24%
Bloodstream Infection
82%
Candida
9%
Candidemia
26%
Carbapenem
50%
Catheter Infection
13%
Cohort Study
53%
Colistimethate
28%
Combination Therapy
10%
Coronavirinae
19%
Cotrimoxazole
10%
Delta Variant
8%
Diseases
22%
Enterobacteriales
17%
Escherichia coli
12%
Extended Spectrum Beta Lactamase
15%
Gram Negative Sepsis
10%
Hematologic Malignancy
17%
Hospital Infection
10%
Infection
34%
Infectious Agent
12%
Klebsiella pneumoniae
11%
Methicillin Resistant Staphylococcus Aureus Infection
9%
Meticillin
16%
Monotherapy
10%
Penicillinase
17%
Pneumonia
27%
Prevalence
17%
Pseudomonas aeruginosa
11%
Quinolone Derivative
11%
Recurrent Disease
15%
Retrospective Study
39%
SARS Coronavirus
8%
Staphylococcal Bacteremia
17%
Staphylococcus aureus
33%
Stenotrophomonas maltophilia
17%
Teicoplanin
19%
Therapeutic Drug Monitoring
17%
Urinary Tract Infection
8%
Vaccination
12%
Vancomycin
11%
Immunology and Microbiology
Adenosine Deaminase
8%
Albumin
8%
All Cause Mortality
11%
Antimicrobial Agent
22%
Antimicrobial Stewardship
17%
Aspergillosis
8%
Breakthrough Infection
8%
Candida
13%
Cell Culture Technique
8%
Cerebrospinal Fluid
11%
Colistin
17%
Comorbidity
10%
COVID-19
50%
Covid-19 Vaccine
8%
Creatinine Clearance
8%
Cytomegalovirus
8%
Enterobacterales
17%
Enterococcus faecium
8%
Enzyme Immunoassay
8%
Gram-Negative Bacteria
8%
Hepatitis B Virus
8%
Herpes Zoster
8%
Host Factor
8%
Human cytomegalovirus
8%
Immunocompromised Patient
10%
Infection
100%
Infectious Disease
100%
Kidney Function
8%
Klebsiella pneumoniae
37%
Maintenance Drug Dose
8%
Meningitis
17%
Middle East Respiratory Syndrome Coronavirus
8%
Minimum Concentration
8%
Minimum Inhibitory Concentration
8%
Multilocus Sequence Typing
8%
Neisseria gonorrhoeae
8%
Optimal Drug Dose
8%
Pertussis
8%
Plasmid
11%
Prevalence
17%
Pseudomonas aeruginosa
25%
Real-Time Polymerase Chain Reaction
10%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Staphylococcus aureus
38%
Stenotrophomonas maltophilia
17%
Susceptibility
17%
Tuberculous Meningitis
8%
Vancomycin Intermediate Staphylococcus Aureus
8%
Vancomycin-Resistant Enterococcus
20%
Zoster Vaccine
8%
Medicine and Dentistry
Antimicrobial Agent
22%
Antimicrobial Stewardship
17%
Asymptomatic Bacteriuria
8%
Bloodstream Infection
35%
Cancer
17%
Catheter Infection
17%
Clinical Feature
10%
Cohort Analysis
10%
COVID-19
50%
Cytomegalovirus
16%
Cytomegalovirus Infection
8%
Deceased Donors
10%
Diagnostic Performance
21%
Diseases
16%
Disseminated Herpes Zoster
8%
Echocardiography
10%
Enzyme Immunoassay
8%
Fungal Infection
8%
Glucan
8%
Health Care Personnel
10%
Hepatitis B Antibody
8%
Hepatitis B Vaccination
8%
High Risk Population
8%
Human cytomegalovirus
8%
Immunocompromised Patient
9%
Infection
36%
Infection Rate
8%
Infectious Disease
8%
Intensive Care Unit
20%
Kidney Graft
8%
Liver Graft
17%
Liver Transplantation
11%
Living Donor
8%
Medical Informatics
8%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Mycosis
10%
Odds Ratio
12%
Pertussis
8%
Pneumocystis Jirovecii
8%
Pneumonia
23%
Real-Time Polymerase Chain Reaction
8%
Retrospective Cohort Study
22%
Retrospective Study
19%
Risk Stratification
8%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Staphylococcus aureus
17%
Surgical Infection
8%
Tuberculosis
17%
Vancomycin Resistant Enterococcus
17%
Varicella Zoster Vaccine
8%
